Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology

• Epidemiological characteristics and transmission dynamics of epidemic Japanese encephalitis in China: A modeling study (September 2025)
• Sheep serve as amplifying hosts of Japanese encephalitis virus, increasing the risk of human infection (May 16, 2025)
• Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study (May 27, 2024)
• Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: A retrospective epidemiological study (May 9, 2023)
• Extent of disability among paediatric Japanese encephalitis survivors and predictors of poor outcome: a retrospective cohort study in North India (October 31, 2022)
• Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization (October 27, 2020)
• Distribution of Japanese Encephalitis Virus, Japan and Southeast Asia, 2016–2018 (January 2020)
• A Nationwide Survey of Pediatric-onset Japanese Encephalitis in Japan (September 24, 2018)
• Recent and historical trends in the epidemiology of Japanese encephalitis and its implication for risk assessment in travelers (May 1, 2018)

Clinical Features, Diagnosis, and Management

• Japanese encephalitis (March 27, 2024)
• Japanese Encephalitis Emergence in Australia: The Potential Population at Risk (October 3, 2022)
• Japanese Encephalitis in Australia — A Sentinel Case (August 17, 2022)
• Proteomic landscape subtype and clinical prognosis of patients with the cognitive impairment by Japanese encephalitis infection (April 4, 2022)
• Guillain–Barré Syndrome Associated with JEV Infection (September 16, 2020)
• Japanese Encephalitis Virus as Cause of Acute Encephalitis, Bhutan (September 2020)
• Screening of Natural Extracts for Inhibitors against Japanese Encephalitis Virus Infection (February 21, 2020)
• Japanese encephalitis — the prospects for new treatments (April 26, 2018)
• Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, China (January 2018)

Vaccination

• From vaccination success to new outbreaks: reassessing Japanese encephalitis control in Nepal (October 9, 2025)
• Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh (December, 2024)
• Genotype III-Based Japanese Encephalitis Vaccines Exhibit Diminished Neutralizing Response to Reemerging Genotype V (November 22, 2024)
• Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh (August 9, 2024)
• Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination (April 29, 2024)
• A decision support tool for risk–benefit analysis of Japanese encephalitis vaccine in travellers (August 21, 2023)
• Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines (March 27, 2023)
• Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis (May 12, 2022)
• Safety and dose-sparing effect of Japanese encephalitis vaccine administered by microneedle patch in uninfected, healthy adults (MNA-J): a randomised, partly blinded, active-controlled, phase 1 trial (December 16, 2021)
• Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis (June 24, 2021)
• The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control (June 15, 2021)
• Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015 (May 26, 2020)
• Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO® in healthy adults: A five year follow-up study (April 5, 2019)
• Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study (March 13, 2018)